Munich, Germany – Fuse-It-siRNA is an innovative new transfection reagent that enables rapid and efficient gene silencing with the highest biocompatibility, even in sensitive and difficult-to-transfect cells, such as primary keratinocytes. ibidi’s novel method for endosome-independent siRNA transfection fully retains cellular functionality and viability. Using Fuse-It-siRNA, the researcher can focus directly on the knockdown phenotype without […]

Jena, Germany – Hepatitis C (HCV) infection is the most common cause of liver cell carcinoma and liver transplants in Europe, which are possible late-stage effects of a chronic infection, alongside cirrhosis of the liver. An antiviral therapy to eliminate the hepatitis C virus allows a treatment and curing of the infection. The standardized approach for […]

In-Depth Genomics Leverages PerkinElmer’s Comprehensive Sequencing Services to Provide Whole Genome Sequencing to Neurology Patients   National Society of Genetic Counselors Annual Conference, Columbus, Ohio, Booth #535 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced an innovative collaboration with In-Depth Genomics (IDG) to support IDG’s Whole Genome Sequencing (WGS) Diagnostic Program that […]

BERGISCH GLADBACH — Miltenyi Biotec is launching a new era in the field of fully automated high-throughput flow cytometry analysis: Now up to 384-well plates can be handled in less than 60 minutes giving users fast, reliable, and reproducible results. This is made possible by the MACSQuant® X – a benchtop instrument that gives you all the […]

MINNEAPOLIS — R&D Systems, a Bio-Techne brand, today announced the release of its new XL Cytokine Discovery Luminex® High Performance Panel.  As with all R&D Systems® Luminex Assays, this new panel is compatible with all Luminex instrumentation systems and has the capability to simultaneously measure the amount of 45 different analytes in a variety of […]

Assay Detects Genetic Anomalies and Helps Move Inquiries from Cause to Care Faster SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization (CGH) assay for diagnostic use. This assay […]

OAKLAND, Calif. & SAN FRANCISCO, Calif.–Fabric Genomics and Genome Medical announced today that they have entered into a partnership with the goal of bringing expert medical interpretation and counseling around genomic data directly to physicians and patients. Genome Medical will use Fabric Genomics’ clinical interpretation platform, Fabric Enterprise™, for ongoing examination of its patients’ genomic data to augment data […]

LAUSANNE, Switzerland SOPHiA GENETICS, the global leader in Data-Driven Medicine that has created SOPHiA Artificial Intelligence, today announced the close of a $30 million Series D funding round. The round was led by London-based Balderton Capital joined by 360º Capital Partners alongside existing investors British tech star Mike Lynch’s Invoke Capital and Alychlo, the investment firm of Belgian pharmaceutical entrepreneur Marc Coucke. […]

vermicon AG and Sysmex Europe GmbH agree on partnership for product distribution  MUNICH   Sysmex Europe GmbH, a subsidiary of the international enterprise Sysmex Corporation, andvermicon AG, hereby announce the start of a business partnership. The first result of this alliance, a combination of flow cytometry and gene probe technology known as the ‘Flow VIT® Solution’ detection system, will provide highly sensitive and sector-specific solutions for industrial microbiology with the aim of raising quality control to a new level.  For almost 50 years, Sysmex Partec GmbH, a subsidiary of the Sysmex […]

– Sizes range from 50-liter to 2,000-liter manufacturing scale – Industry-leading design offers flexibility, scalability and ease-of-use BILLERICA, Mass. — MilliporeSigma today announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of MilliporeSigma’s Mobius® single-use bioreactors. Celonic, which produces biosimilars and also offers a cell line development platform, […]